Related Experiment Video
Updated: Jun 27, 2026
08:01
The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Genetics of bleeding disorders in women
Enrico M Novelli1, Margaret V Ragni
1Department of Medicine, Division of Hematology and Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Seminars in Thrombosis and Hemostasis
|December 17, 2008
Summary
Genetic analysis is revolutionizing von Willebrand disease (VWD) management. Understanding VWD genetics aids diagnosis, predicts severity, and guides personalized treatment for women with inherited bleeding disorders.
Area of Science:
- Genetics and Genomics
- Hematology
- Women's Health
Background:
- Von Willebrand disease (VWD) classification and understanding are increasingly influenced by genetic factors.
- Prospective studies in Europe, Canada, and the US highlight the growing importance of VWD genotype-phenotype correlations.
Purpose of the Study:
- To review the genetics of inherited bleeding disorders specifically in women.
- To focus on bleeding manifestations, diagnostic approaches, and management strategies informed by genetic insights.
Main Methods:
- Review of current prospective studies on VWD genotype and phenotype.
- Analysis of the evolving role of genetic sequencing in VWD diagnosis and management.
- Synthesis of information on inherited bleeding disorders in women.
Main Results:
- Genetics is becoming central to VWD classification, understanding, and treatment.
- Genetic analysis is expected to improve diagnosis, predict clinical severity, and guide individualized management.
- The relationship between genotype and phenotype is crucial for predicting treatment response.
Conclusions:
- Genetic analysis is poised to significantly impact the diagnosis, prediction of severity, and individualized management of VWD.
- The field is rapidly evolving, promising changes in how bleeding disorders in women are managed.
- Continued research into VWD genetics is essential for optimizing patient care.
Related Concept Videos
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:19X-linked Traits
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
01:19X-linked Traits
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:35Pedigree Analysis
Overview
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...